Evoke Wealth, LLC

SEC CIK: 0001793432
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

NKTR holding history

Nektar Therapeutics in every 13F filed by Evoke Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overview All 13F holders of NKTR Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2021

Holdings of NKTR by Evoke Wealth, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−5,973−100.0%	Sold out	Holders
Q1 2022	5,973	$32.0K	<0.1%	−2,027−25.3%	Reduced	Holders
Q4 2021	8,000	$108.0K	<0.1%	00.0%	Unchanged	Holders
Q3 2021	8,000	$143.0K	<0.1%	+8,000	New	Holders